Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 4 a 23 di 53
Titolo Data di pubblicazione Autore(i) File
Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma. 2005 RIGACCI L; CARRAI V; NASSI L; ALTERINI R; LONGO G; BERNARDI F; A. BOSI
Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive bresat cancer:the preoperative "Arimidex" compared to Tamoxifen (PROACT) trial. 2006 L. CATALIOTTI; BUZDAR AU; NOGUCHI S; BINES J; TAKATSUKA Y; PETRAKOVA K; DUBE P; TOSELLO DE OLIVEIRA C
Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens 2015 Thompson, Philip A; O'Brien, Susan M.; Wierda, William G.; Ferrajoli, Alessandra; Stingo, Francesco; Smith, Susan C.; Burger, Jan A.; Estrov, Zeev; Jain, Nitin; Kantarjian, Hagop M.; Keating, Michael J.
Congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis: novel criteria of assesment and correlations with constitutional adenomatous polyposis coli gene mutations. 1996 R. VALANZANO; CAMA A.; VOLPE R.; CURIA MC.; MENCUCCI R.
Consensus Conference on the treatment of in situ ductal carcinoma of the breast April 22-25 1999 2000 SCHWARTZ G.F.; SOLIN L.J.; OLIVOTTO I.A.; THE CONSENSUS CONFERENCE COMMITTEE; L. CATALIOTTI
Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes. 2011 L.R. Silverman ; P.Fenaux ; G.J.Mufti ; V.Santini ; E.Hellström-Lindberg ; N.Gattermann ; G. Sanz ; A.F. List ; S.D.Gore ; J.F. Seymour
Cytopathological diagnosis in a cancer registry: a useful diagnostic tool? 2007 Caldarella A.; Crocetti E.; Taddei G.L.; Paci E.
CYTOTOXIC/NATURAL KILLER CELL CUTANEOUS LYMPHOMAS: REPORT OF THE E.O.R.T.C. CUTANEOUS LYMPHOMA TASK FORCE WORKSHOP. 2003 M. SANTUCCI; N. PIMPINELLI; D. MASSI; M.E. KADIN; C.J.L.M. MEIJER; H.K. MULLER-HERMELINK; M. PAULLI; J. WECHSLER; R. WILLEMZE; H. AUDRING; M.G. BERNENGO; L. CERRONI.
Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase. 2009 Kantarjian HM; Larson RA; Guilhot F; O'Brien SG; Mone M; Rudoltz M; Krahnke T; Cortes J; Druker BJ; International Randomized Study of Interferon and STI571 (IRIS) Investigators. Durant S; Schwarer A; Joske D; Seymour J; Grigg A; Ma D; Arthur C; Bradstock K; Joshua D; Louwagi A; Martiat P; Bosly A; Shistok C; Lipton J; Forrest D; Walker I; Roy DC; Rubinger M; Bence-Bruckler I; Stewart D; Kovacs M; Turner AR; Birgens H; Bjerrum O; Facon T; Harousseau JL; Tulliez M; Guerci A; Blaise D; Maloisel F; Michallet M; Andreesen R; Nerl C; Freund M; Gattermann N; Ehninger G; Deininger M; Ottmann O; Peschel C; Fruehauf S; Neubauer A; le Coutre P; Aulitzky W; Fanin R; Rosti G; Mandelli F; Lazzarino M; Morra E; Carella A; Petrini M; Nobile F; Liso V; Ferrara F; Rizzoli V; Fiortoni G; Martinelli G; Ossenkoppele G; Browett P; Gedde-Dahl T; Tangen JM; Dahl I; Odrizoala J; Hernandez Boulda JC; Steegman JL; Canizo C; Diaz J; Grenena A; Fernandez MN; Stenke L; Paul C; Bjoreman M; Malm C; Wadenvik H; Nilsson PG; Turesson I; Hess U; Solenthaler M; Clark RE; Green AR; Holyoake TL; Lucas GS; Smith G; Milligan DW; Rule SJ; Burnett AK; Moroose R; Wetzler M; Bearden J; Cataland S; Robinowitz I; Meisenberg B; Thompson K; Graziano S; Emanuel P; Gross H; Cobb P; Bhatia R; Dakhil S; Irwin D; Issell B; Pavletic S; Kuebler P; Layhe E; Butra P; Glass J; Moore J; Grant B; Neill H; Herzig R; Burris H; Petersen B; Kalaycio M; Stirewalt D; Samlowski W; Berman E; Limentani S; Seay T; Shea T; Akard L; Smith G; Becker P; Devine S; Hart R; Veith R; Wade J; Brunvad M; Kalman L; Strickland D; Shurafa M; Bashey A; Shadduck R; Safah H; Rubenstein M; Collins R; Keller A; Tallman M; Pecora A; Agha M; Homes H; Guidice R; Santini V. Kantarjian HM; Larson RA; Guilhot F; O'Brien SG; Mone M; Rudoltz M; Krahnke T; Cortes J; Druker BJ; International Randomized Study of Interferon and STI571 (IRIS) Investigators. Durant S; Schwarer A; Joske D; Seymour J; Grigg A; Ma D; Arthur C; Bradstock K; Joshua D; Louwagi A; Martiat P; Bosly A; Shistok C; Lipton J; Forrest D; Walker I; Roy DC; Rubinger M; Bence-Bruckler I; Stewart D; Kovacs M; Turner AR; Birgens H; Bjerrum O; Facon T; Harousseau JL; Tulliez M; Guerci A; Blaise D; Maloisel F; Michallet M; Andreesen R; Nerl C; Freund M; Gattermann N; Ehninger G; Deininger M; Ottmann O; Peschel C; Fruehauf S; Neubauer A; le Coutre P; Aulitzky W; Fanin R; Rosti G; Mandelli F; Lazzarino M; Morra E; Carella A; Petrini M; Nobile F; Liso V; Ferrara F; Rizzoli V; Fiortoni G; Martinelli G; Ossenkoppele G; Browett P; Gedde-Dahl T; Tangen JM; Dahl I; Odrizoala J; Hernandez Boulda JC; Steegman JL; Canizo C; Diaz J; Grenena A; Fernandez MN; Stenke L; Paul C; Bjoreman M; Malm C; Wadenvik H; Nilsson PG; Turesson I; Hess U; Solenthaler M; Clark RE; Green AR; Holyoake TL; Lucas GS; Smith G; Milligan DW; Rule SJ; Burnett AK; Moroose R; Wetzler M; Bearden J; Cataland S; Robinowitz I; Meisenberg B; Thompson K; Graziano S; Emanuel P; Gross H; Cobb P; Bhatia R; Dakhil S; Irwin D; Issell B; Pavletic S; Kuebler P; Layhe E; Butra P; Glass J; Moore J; Grant B; Neill H; Herzig R; Burris H; Petersen B; Kalaycio M; Stirewalt D; Samlowski W; Berman E; Limentani S; Seay T; Shea T; Akard L; Smith G; Becker P; Devine S; Hart R; Veith R; Wade J; Brunvad M; Kalman L; Strickland D; Shurafa M; Bashey A; Shadduck R; Safah H; Rubenstein M; Collins R; Keller A; Tallman M; Pecora A; Agha M; Homes H; Guidice R; Santini V.
EPITHELIAL OVARIAN TUMORS IN THE REPRODUCTIVE AGE GROUP: AGE IS NOT AN INDEPENDENT PROGNOSTIC FACTOR 1996 D. MASSI; T. SUSINI; L. SAVINO; V. BODDI; G. AMUNNI; M. COLAFRANCESCHI.
Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck 2002 A. FRANCHI; M. SANTUCCI; E. MASINI; I. SARDI; M. PAGLIERANI; O. GALLO
Gastric cancer in a high-risk area in Italy: Histopathologic patterns according to Lauren's classification 1988 Amorosi; A.; Bianchi; S.; Buiatti; E.; Cipriani; F.; Palli; D.; Zampi; G.
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients. 2005 Marchi E;Alinari L;Tani M;Stefoni V;Pimpinelli N;Berti E;Pagano L;Bernengo MG;Zaja F;Rupoli S;Pileri S;Baccarani M;Zinzani PL
Gender differences in non-small cell lung cancer: a population-based study 2007 CALDARELLA A; CROCETTI E; C. COMIN; JANNI A; PEGNA AL; PACI E
Genetic alterations between primary head and neck squamous cell carcinoma and recurrence after radiotherapy 2010 A.Deganello; A.Franchi; I.Sardi; L.Pignataro; CR. Leemans; O.Gallo
Homoharringtonine: history, current research, and future direction. 2001 KANTARJIAN HM; TALPAZ M; V. SANTINI; MURGO A; CHESON B; O'BRIEN SM.
Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. 2005 G. CSERNI; S. BIANCHI; W. BOECKER ET AL
Increase of the mitotic index of colonic mucosa after cholecystectomy. 1986 L. Bandettini; F. Filipponi; P. Romagnoli
Long-term follow-up of patients with acute myeloid leukemia surviving and free of disease recurrence for at least 2 years after autologous stem cell transplantation: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 2016 Czerw, Tomasz; Labopin, Myriam; Gorin, Norbert-Claude; Giebel, Sebastian; Blaise, Didier; Meloni, Giovanna; Pigneux, Arnaud; Bosi, Alberto; Veelken, Joan; Ferrara, Felicetto; Schaap, Nicolaas; Lemoli, Roberto M.; Cornelissen, Jan J.; Beohou, Eric; Nagler, Arnon; Mohty, Mohamad
Long-term immunotherapy with low-dose interleukin-2 and interferon-alpha in the treatment of patients with advanced renal cell carcinoma 2001 Buzio, C; Andrulli, S; Santi, R; Pavone, L; Passalacqua, R; Potenzoni, D; Ferrozzi, F; Giacosa, R; Vaglio, A
Mostrati risultati da 4 a 23 di 53
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile